Joshua Wayne Clark, | |
4037 Ste A 214, Phelan, CA 92371 | |
(760) 964-0153 | |
Not Available |
Full Name | Joshua Wayne Clark |
---|---|
Gender | Male |
Speciality | Psychologist - Intellectual & Developmental Disabilities |
Location | 4037 Ste A 214, Phelan, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053197517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TM1800X | Psychologist - Intellectual & Developmental Disabilities | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joshua Wayne Clark, 4037 Ste A 214, Phelan, CA 92371 Ph: (760) 964-0153 | Joshua Wayne Clark, 4037 Ste A 214, Phelan, CA 92371 Ph: (760) 964-0153 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
"A rush by farmers to expand plantings in many parts of the world is raising expectations that food prices may retreat as early as the second half of this year if weather conditions remain favorable," the Wall Street Journal reports in a story examining how recent global developments could affect food price spikes.
"Nations have crafted a draft treaty to fight a booming trade in illicit tobacco products that's costing governments as much as $50 billion a year in lost tax revenue, officials said Wednesday," the Associated Press/Washington Post reports.
Bisphosphonates have been shown to reduce the risk of osteoporotic fractures. To avoid possible side effects of long-term therapy, many patients take a drug holiday after several years of bisphosphonate therapy.
› Verified 5 days ago